Quality care is our passion
“ CFM is providing new standards in tissue repair. ”
CFM is continuously investigating new drug compounds to ensure cutting edge therapies in trauma care at great length.
CFM Pharma Holding BV (CFM) is a private Dutch pharmaceutical company with a unique patented tissue protection and tissue repair technology platform...
Traumatic injuries have major health consequences. Expert multidisciplinary trauma care is recognized as the most important determinant of survival...
Members of the research team of the Beverwijk Burns Centre are strongly supporting the BMOV drug development program as conducted by CFM...
CFM has several promising new vanadium compounds and combination therapies with synergistic compounds in the pipeline that further improve patient’s outcome..
The BMOV drug development program as conducted by CFM concerning AMI aims at a superior systemic treatment based on the beneficial effects of intravenous administration of organic vanadium compounds..
Traditional Drug Development is extremely costly and is consuming up to 15 years of development time, while the chance of failure is high ..